https://www.berndailypress.com/article/908365075-swiss-quantum-safe-l1-qorechain-launches-guardians-program-with-on-chain-credentials-and-capped-ranks Bern Daily Press en PressRelease 2026-04-27T12:00:00+00:00 Swiss Quantum-Safe L1 QoreChain Launches Guardians Program with On-Chain Credentials and Capped Ranks https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24841257-qorechain-guardians-cohort-1-a-1200x630.png https://www.berndailypress.com/article/908406388-patrick-mimran-billboard-project Bern Daily Press en PressRelease 2026-04-27T09:46:19+00:00 PATRICK MIMRAN BILLBOARD PROJECT https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24841394-billboard-quote-2-2000x900.jpeg https://www.berndailypress.com/article/908400191-patrick-mimran-recent-works Bern Daily Press en PressRelease 2026-04-27T09:23:38+00:00 PATRICK MIMRAN RECENT WORKS https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24841346-interferences-1598x2000.jpeg https://www.berndailypress.com/article/908418125-every-minute-counts-eaaci-calls-for-urgent-action-to-make-schools-safe-for-children-at-risk-of-anaphylaxis Bern Daily Press en PressRelease 2026-04-27T10:07:26+00:00 Every minute counts: EAACI calls for urgent action to make schools safe for children at risk of anaphylaxis https://ml-eu.globenewswire.com/media/ca605fbb-0ff4-40ba-be81-fbfc0b45538c/medium/official-representatives-from-eaaci-aepnaa-seaic-and-seicap.jpeg https://www.berndailypress.com/article/908378484-santhera-erh-lt-positive-stellungnahme-des-chmp-zur-ausweitung-der-anwendung-von-agamree-vamorolon-bei-p-diatrischen-dmd-patienten-ab-zwei-jahren Bern Daily Press en PressRelease 2026-04-27T05:00:00+00:00 Santhera erhält positive Stellungnahme des CHMP zur Ausweitung der Anwendung von AGAMREE® (Vamorolon) bei pädiatrischen DMD-Patienten ab zwei Jahren in der EU https://ml-eu.globenewswire.com/media/63cd960e-70ce-4ba8-8984-92f72954c235/small/ https://www.berndailypress.com/article/908378495-santhera-receives-positive-chmp-opinion-to-expand-agamree-vamorolone-use-in-pediatric-dmd-patients-aged-two-and-older-in-the-eu Bern Daily Press en PressRelease 2026-04-27T05:00:00+00:00 Santhera Receives Positive CHMP Opinion to Expand AGAMREE® (vamorolone) Use in Pediatric DMD Patients Aged Two and Older in the EU https://ml-eu.globenewswire.com/media/63cd960e-70ce-4ba8-8984-92f72954c235/small/logo-jpg.JPG